How Long After Exposure a Test Is Accurate

A test does not look for "an infection" in the abstract — it looks for something specific: the pathogen's genetic material, a piece of the pathogen itself, or the antibodies your immune system produces in response. After an exposure, the amount of that target starts below what any test can detect and rises over days to weeks. The window period is the stretch of time between the exposure and the moment the target becomes reliably detectable.

This is why timing and accuracy are inseparable. A test taken too soon after exposure can miss a recent infection — the method can be excellent and the result still negative, simply because there was not yet enough to detect on the day the sample was collected. Every range on this page should be read with that rule attached.

One honest caveat up front: CDC does not publish a single universal window-period table covering every STI. The ranges below combine CDC-published test guidance with clinical guidance commonly used in practice, and they are ranges rather than countdown clocks — individual timing varies, and a clinician can sequence testing to your specific exposure.

There are three families of tests, and three clocks. Nucleic acid amplification tests (NAAT) find the pathogen's genetic material directly and typically turn positive soonest. Antigen tests look for proteins on the pathogen itself. Antibody tests wait for your immune system to respond — which takes longer, and varies by infection and by person. That is the biology behind every window period on this page.

HIV shows the spread cleanly, because its windows are the most precisely documented. A 4th-generation lab antigen/antibody test has a CDC-documented window of roughly 18 to 45 days. An HIV RNA (nucleic acid) test window runs about 10 to 33 days — earlier detection, but still not instant. Either way, an exposure from last week is inside the window, and a test drawn today cannot rule it out.

Chlamydia and gonorrhea are usually detected with NAAT on urine or a swab. CDC treatment guidance describes NAAT as the most sensitive method available for these specimens, but CDC does not publish one fixed number of days to wait. Clinical guidance commonly used in practice places the window at roughly 1 to 2 weeks after a possible exposure — and a test run sooner can miss a recent infection, which is why clinicians often plan a follow-up rather than trust a very early negative.

Syphilis is tested in two steps — a treponemal test plus a non-treponemal test such as RPR — and early on it can hide: a person in the early chancre stage can still test negative on serology. That is why retesting intervals of about 4 to 6 weeks, and again around 3 months after a concerning exposure, are common clinical practice rather than optional extras.

For herpes, type-specific IgG blood tests generally become meaningful around 6 weeks to 3 months after exposure — antibodies simply take time to develop. CDC guidance advises retesting at about 12 weeks in some contexts, and evidence reviewers including the USPSTF have flagged that these blood tests can return false-positive results in people at low risk. Both facts point the same direction: an early or single herpes result deserves confirmation rather than panic or premature relief.

Hepatitis C antibody tests typically turn positive on the order of 8 to 11 weeks, while hepatitis C RNA can be found within about 1 to 2 weeks of infection; hepatitis B surface antigen can appear within a few weeks of a new infection. These are hepatitis-guidance ranges, hedged the same way as everything else here — your specific exposure is a conversation for a clinician, not a lookup table.

Trichomoniasis is caused by a parasite, and CDC's parasitology reference documents an incubation period of roughly 5 to 28 days. NAAT is the recommended detection method. Here is the honest part: unlike HIV, trichomoniasis has no single published universal testing window — clinical judgment fills the gap, and any specific day-count you find online deserves skepticism.

The rule that survives every gap in the data: a test taken too soon after exposure can miss a recent infection. A trich test drawn the day after an exposure is plausibly too early; the 5-to-28-day incubation range is exactly why a clinician may suggest retesting rather than treating one early result as final.

An early negative is the most common way people talk themselves out of a real risk. If a chlamydia test runs three days after an exposure, the NAAT may find nothing — not because the person is in the clear, but because there is nothing yet above the detection threshold. The fix is unglamorous: test on a timeline matched to the infection, and repeat when the first test was drawn inside the window.

Retest intervals that recur across clinical guidance: about 1 to 2 weeks for chlamydia and gonorrhea after a concerning exposure; about 4 to 6 weeks and again around 3 months for syphilis serology; about 12 weeks for herpes IgG when an early result needs confirming; and the CDC windows for HIV — roughly 18 to 45 days for 4th-generation lab tests, sooner for RNA. A negative result is always a snapshot of the day the sample was collected; if exposures have continued since, the snapshot is out of date.

The first step after a known exposure is not a test — it is a conversation. A clinician can sequence testing by infection and urgency, and can discuss whether HIV post-exposure prophylaxis (PEP) is appropriate: CDC guidance holds that PEP is most effective when started within 72 hours, which makes that decision genuinely time-sensitive. Everything else on this page can wait until morning; that conversation ideally cannot.

For routine sequencing, the lab network this site recommends publishes its own retest guidance alongside its pricing: test about 3 weeks after an initial exposure, then again at 3 months, because different infections become detectable at different times. Paired with the per-infection ranges above, that cadence covers the common clinical logic — early pick-up of bacterial infections, later confirmation for antibodies.

If a first test was already taken inside the window, the answer to "was it too early?" is almost always "plan the follow-up." Testing early is never wrong; expecting an early negative to be final is. A clinician can order the right retest, and a negative drawn at the right interval is what actually closes the question.